Loss of Neutrophils and SLPI Reshapes Early Mucosal Inflammatory Responses During Intranasal Vaccination
European Journal of Immunology · 2026
DOI: 10.1002/eji.70282 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2026. Verfasst von Oktawia Osiecka und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Faculty of Biochemistry, Biophysics, and Biotechnology, Jagiellonian University, Kraków, Poland. Hauptthemen laut MEDLINE: Neutrophils, Secretory Leukocyte Peptidase Inhibitor, Immunity, Mucosal, Bordetella pertussis. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre in Poland and the European Union's Horizon 2020, Strategic Programme Excellence Initiative at Jagiellonian University, TEAM NET Programme of the Foundation for Polish Science.
Abstract (Originalsprache)
Vaccines delivered via the nasal route have attracted increasing attention for their capacity to engage the mucosal immune system at the primary site of pathogen entry. However, the early innate mechanisms that shape local immune responses following nasal immunisation remain poorly defined. Here, we identified previously uncharacterised tissue‐derived mediators induced during vaccination. Using an intranasally administered whole‐cell pertussis (wP) vaccine that recapitulates key features of Bordetella pertussis infection and elicits long‐lasting immunity, we show that nasal delivery triggers neutrophil recruitment along with a marked upregulation of secretory leukocyte protease inhibitor (SLPI). Employing SLPI‐ and neutrophil‐deficient mouse models, we demonstrate that SLPI and neutrophils influence the production of key mediators associated with coagulation (PAI‐1) and tissue remodelling (MMP‐3 and MMP‐9) within the airway. Notably, neutrophils also modulate early local total IgA release. Together, these findings suggest a coordinated and context‐dependent interplay between cellular and soluble innate components that shape early mucosal immune responses. Furthermore, identified mediators may represent candidate biomarkers in the development of intranasal vaccines against B. pertussis and other pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, Faculty of Biochemistry, Biophysics, and Biotechnology, Jagiellonian University, Kraków, Poland.
- Doctoral School of Exact and Natural Sciences, Jagiellonian University, Kraków, Poland.
- Department of Microbiology, Faculty of Biochemistry, Biophysics, and Biotechnology, Jagiellonian University, Kraków, Poland.
Förderung
- National Science Centre in Poland and the European Union's Horizon 2020
- Strategic Programme Excellence Initiative at Jagiellonian University
- TEAM NET Programme of the Foundation for Polish Science
Zitieren
APA
Osiecka, O., Tyshchenko, M., Sinkevich, I., Pocałuń, N., Cichy, J., Kwiecinski, J. M., Oleszycka, E., & Wilk, M. M. (2026). Loss of Neutrophils and SLPI Reshapes Early Mucosal Inflammatory Responses During Intranasal Vaccination. European Journal of Immunology. https://doi.org/10.1002/eji.70282
Vancouver
Osiecka O, Tyshchenko M, Sinkevich I, Pocałuń N, Cichy J, Kwiecinski JM, et al. Loss of Neutrophils and SLPI Reshapes Early Mucosal Inflammatory Responses During Intranasal Vaccination. European Journal of Immunology. 2026. doi:10.1002/eji.70282
BibTeX
@article{Osiecka2026,
author = {Osiecka, Oktawia and Tyshchenko, Mariia and Sinkevich, Ivan and Pocałuń, Natalia and Cichy, Joanna and Kwiecinski, Jakub M and Oleszycka, Ewa and Wilk, Mieszko M},
title = {Loss of Neutrophils and SLPI Reshapes Early Mucosal Inflammatory Responses During Intranasal Vaccination},
journal = {European Journal of Immunology},
year = {2026},
doi = {10.1002/eji.70282}
}
EUVIMED